Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Methyl 4-iodo-3-methylbenzoate, 98%
Click to view available options
Quantity:
5 g
25 g
100 g
Description
Methyl 4-iodo-3-methylbenzoate is used in the synthesis of novel colchicine-derived nitrate esters as immunosuppressant agents.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Methyl 4-iodo-3-methylbenzoate is used in the synthesis of novel colchicine-derived nitrate esters as immunosuppressant agents.
Solubility
Slightly soluble in methanol.
Notes
Light sensitive. Store away from oxidizing agents, light.
Methyl 4-iodo-3-methylbenzoate is used in the synthesis of novel colchicine-derived nitrate esters as immunosuppressant agents.
Solubility
Slightly soluble in methanol.
Notes
Light sensitive. Store away from oxidizing agents, light.

Specifications
Specifications
Melting Point | 59°C to 62°C |
Quantity | 100 g |
Sensitivity | Light sensitive |
Solubility Information | Slightly soluble in methanol. |
Formula Weight | 276.07 |
Percent Purity | 98% |
Chemical Name or Material | Methyl 4-iodo-3-methylbenzoate |
Safety and Handling
Hazard Category | H315-H319-H335 |
Hazard Statement | GHS H Statement H315-H319-H335 Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
Precautionary Statement | P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P362-P501c |
TSCA | No |
Recommended Storage | Ambient temperatures |
RUO – Research Use Only
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction